Form 4: Director Leslie Wims Morris Acquires IQVIA Deferred Shares

IQVIA Holdings Inc. director Leslie Wims Morris acquired 1,571 deferred shares as part of the company's non-employee director compensation plan.

Summary

• Director Leslie Wims Morris was granted 1,571 deferred shares of IQVIA Holdings Inc. common stock.
• The transaction occurred on April 23, 2026, at a price of $160.68 per share.
• Following this transaction, the director holds a total of 6,465 shares directly.
• Deferred shares are convertible into common stock upon the director's departure from the board, a change in control, or death.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Increased equity alignment between the director and shareholders.

Negatives

• None identified.

Risks

• Value of deferred shares is subject to market fluctuations in IQVIA common stock price.

Future Outlook

The deferred shares will convert to common stock upon the director's cessation of service, a change in control, or death, with no expiration date.

Industry Context

StockSavvy.ai notes that director equity grants are standard practice in the healthcare technology and clinical research sector to ensure long-term alignment with shareholder interests.

Comparison to Industry Standards

• The grant follows standard corporate governance practices for non-employee director compensation among S&P 500 companies.
• The use of deferred share units is a common mechanism to defer tax liability and maintain long-term board commitment.

Corporate Governance

Stakeholder Impact

• Shareholders benefit from increased director equity ownership, which aligns board incentives with long-term value creation.

Next Steps

• No further actions required by the reporting person regarding this specific transaction.

Key Dates

Keywords

IQVIA, IQV, Insider Trading, Form 4, Director Compensation, Equity Grant